TrialThe international journal of neuropsychopharmacology2022

Enhanced Taste Recognition Following Subacute Treatment With The Dopamine D2/D3 Receptor Agonist Pramipexole in Healthy Volunteers.

Alexander Kaltenboeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.